Meeder Asset Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,739
| Closed | -$65K | – | 2051 |
|
|
2021
Q3 | $65K | Buy |
1,739
+1,273
| +273% | +$47.6K | ﹤0.01% | 1020 |
|
|
2021
Q2 | $20K | Buy |
+466
| New | +$20K | ﹤0.01% | 1461 |
|
|
2020
Q3 | – | Sell |
-3,655
| Closed | -$185K | – | 2341 |
|
|
2020
Q2 | $185K | Buy |
3,655
+1,627
| +80% | +$82.4K | 0.01% | 619 |
|
|
2020
Q1 | $89K | Sell |
2,028
-3,701
| -65% | -$162K | 0.01% | 745 |
|
|
2019
Q4 | $275K | Buy |
5,729
+3,991
| +230% | +$192K | 0.02% | 517 |
|
|
2019
Q3 | $60K | Buy |
1,738
+1,667
| +2,348% | +$57.5K | ﹤0.01% | 952 |
|
|
2019
Q2 | $3K | Buy |
+71
| New | +$3K | ﹤0.01% | 1802 |
|
|
2019
Q1 | – | Sell |
-1,068
| Closed | -$37K | – | 1817 |
|
|
2018
Q4 | $37K | Buy |
1,068
+89
| +9% | +$3.08K | ﹤0.01% | 892 |
|
|
2018
Q3 | $47K | Sell |
979
-3,073
| -76% | -$148K | ﹤0.01% | 795 |
|
|
2018
Q2 | $137K | Buy |
+4,052
| New | +$137K | 0.01% | 570 |
|
|
2018
Q1 | – | Sell |
-430
| Closed | -$8K | – | 1709 |
|
|
2017
Q4 | $8K | Buy |
430
+47
| +12% | +$874 | ﹤0.01% | 1196 |
|
|
2017
Q3 | $8K | Buy |
383
+334
| +682% | +$6.98K | ﹤0.01% | 1134 |
|
|
2017
Q2 | $1K | Sell |
49
-109
| -69% | -$2.22K | ﹤0.01% | 1541 |
|
|
2017
Q1 | $2K | Sell |
158
-1,983
| -93% | -$25.1K | ﹤0.01% | 1394 |
|
|
2016
Q4 | $24K | Sell |
2,141
-2,444
| -53% | -$27.4K | ﹤0.01% | 630 |
|
|
2016
Q3 | $64K | Sell |
4,585
-7,598
| -62% | -$106K | 0.01% | 633 |
|
|
2016
Q2 | $86K | Buy |
+12,183
| New | +$86K | 0.01% | 679 |
|
|
2016
Q1 | – | Sell |
-678
| Closed | -$22K | – | 903 |
|
|
2015
Q4 | $22K | Buy |
+678
| New | +$22K | ﹤0.01% | 736 |
|